# LIDOCRIT : Effect of Continuous Intravenous LIDOcaine on Discomfort in Postoperative CRITical Care Inpatients

> **NCT07043023** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Rennes University Hospital** · enrollment: 246 (estimated)

## Conditions studied

- Post-surgery Critical Incare

## Interventions

- **DRUG:** Lidocaine (drug)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07043023
- **Lead sponsor:** Rennes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2027-12-01
- **Final completion:** 2028-06-01
- **Target enrollment:** 246 (ESTIMATED)
- **Last updated:** 2025-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07043023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07043023, "LIDOCRIT : Effect of Continuous Intravenous LIDOcaine on Discomfort in Postoperative CRITical Care Inpatients". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07043023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*